Clinical Trial Update: Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and whole blood activity measurements of PNU-100480 after multiple oral doses in healthy ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• PNU-100480

Snippet

Sponsor: Sequella, Inc. | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED